Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel and Bevacizumab vs Ipilimumab in Metastatic Melanoma
NCT02158520Phase 2Completed
- Sponsor
- Academic and Community Cancer Research United
- Start
- Oct 2013
- Primary completion
- May 2017
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, bevacizumab in melanoma, sponsored by Academic and Community Cancer Research United. Started Oct 2013; status: completed.
02
Drugs
paclitaxelbevacizumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02158520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158520.